Accurate drug labeling is fundamental to ensuring patient safety, regulatory compliance, and successful global commercialization. From developing Company Core Data Sheets (CCDS) and regulatory Product Information to managing safety-driven labeling updates and preparing for electronic Product Information (ePI), every stage requires scientific expertise, regulatory knowledge, and robust lifecycle management.
At Billev Pharma East, we provide comprehensive drug labeling services that support pharmaceutical companies worldwide throughout the entire lifecycle of their medicines. Our multidisciplinary team combines Regulatory Affairs, Pharmacovigilance, Medical Writing, and Digital Regulatory expertise to ensure your Product Information remains accurate, compliant, and globally aligned.
Many organisations associate drug labeling with preparing a Summary of Product Characteristics (SmPC), package leaflet, or carton text. In reality, these documents represent only the final output of a much broader regulatory process.
Together, these documents form the regulated Product Information that healthcare professionals, patients, and regulatory authorities rely on throughout the lifecycle of a medicine.
Every successful labeling strategy begins with a scientifically robust Company Core Data Sheet (CCDS), which serves as the global reference for all regional Product Information. As new clinical evidence, pharmacovigilance findings, literature data, regulatory decisions, and benefit-risk evaluations emerge, Product Information must be continuously reviewed, updated, and implemented across all affected markets.
Whether a medicine is marketed in a single country or across multiple regions, effective drug labeling ensures that global scientific data are translated into consistent regional Product Information while meeting local regulatory requirements.
This continuous lifecycle approach ensures that healthcare professionals and patients always receive accurate, up-to-date information while helping marketing authorisation holders remain compliant with evolving regulatory requirements.
Effective drug labeling therefore requires coordinated collaboration between Regulatory Affairs, Medical Writing, Pharmacovigilance, Quality, and local affiliates to ensure that every change is scientifically justified, globally consistent, and implemented without unnecessary delays.
At Billev Pharma East, we support pharmaceutical companies with every aspect of drug labeling, from initial document development to long-term lifecycle management.
Billev farmacija vzhod, d. o. o.
Billev Pharma East Ltd.
Tržaška cesta 202
1000 Ljubljana
Slovenia
Every successful drug labeling strategy begins with a robust Company Core Data Sheet (CCDS) and Company Core Safety Information (CCSI). We develop, maintain, and update these global reference documents, ensuring that Product Information remains scientifically accurate, aligned with emerging safety data, and consistent across all markets. By integrating Regulatory Affairs and Pharmacovigilance expertise, we help ensure your global labeling strategy remains consistent across worldwide markets while evolving alongside your medicine throughout its lifecycle.
We prepare, review, update, and maintain all regulatory Product Information required throughout the lifecycle of a medicine, including Summary of Product Characteristics (SmPC), Package Leaflets (PIL), prescribing information, carton and label text, and region-specific Product Information. Our experts ensure every document remains scientifically consistent with your Company Core Data Sheet and global drug labeling strategy while meeting regional regulatory requirements.
Managing drug labeling across multiple markets requires balancing global consistency with regional regulatory requirements. We help pharmaceutical companies establish effective labeling strategies, governance processes, and change control while adapting Product Information to country-specific requirements. Our coordinated approach enables consistent implementation across worldwide markets while maintaining alignment with the Company Core Data Sheet and supporting country-specific regulatory compliance.
Product Information is continuously evolving throughout a medicine’s lifecycle. We manage drug labeling updates resulting from pharmacovigilance activities, safety signals, PSURs, PBRERs, new clinical evidence, regulatory authority requests, and post-authorisation variations. By coordinating updates across global and regional markets, we help maintain compliant, consistent, and scientifically justified Product Information while reducing operational complexity.
We also help organisations coordinate global implementation, ensuring that approved labeling changes are consistently reflected across all affected markets.
As regulatory frameworks continue to evolve, we also help organisations prepare Product Information for structured electronic Product Information (ePI). Whether you are planning your transition to ePI or integrating digital Product Information into your broader drug labeling strategy, our experts provide practical guidance from planning through implementation.
Managing drug labeling requires scientific expertise, regulatory knowledge, and continuous coordination throughout the product lifecycle. At Billev Pharma East, we combine Regulatory Affairs, Pharmacovigilance, Medical Writing, and digital regulatory expertise to deliver an integrated service that keeps Product Information accurate, compliant, and globally aligned.
Partnering with Billev Pharma East gives pharmaceutical companies worldwide access to:
Rather than preparing individual documents, we become an extension of your regulatory team, helping you establish efficient labeling processes that remain sustainable throughout the lifecycle of your medicines.
Successful drug labeling requires far more than producing regulatory documents—it requires continuous scientific oversight, regulatory expertise, and proactive lifecycle management.
Our multidisciplinary team supports pharmaceutical companies throughout every stage of Product Information management—from developing Company Core Data Sheets and defining global labeling strategies to maintaining Product Information, implementing safety-driven updates, and preparing for electronic Product Information. By bringing together Regulatory Affairs, Pharmacovigilance, Medical Writing, and digital regulatory expertise, we deliver a fully integrated approach that helps reduce compliance risk, improve operational efficiency, and keep your Product Information aligned throughout the lifecycle of every medicine.
Whether you need support with a single labeling update, a global Product Information project, or complete drug labeling lifecycle management across multiple markets, our experts are ready to help.
With a focus on expert guidance and strategic insights, we propel your projects forward with confidence, ensuring every step is handled with precision.
Regulatory Affairs
Pharmacovigilance
Medical Consultancy
Medical Affairs
Quality/GxP
Digital Consultancy
Medical Devices and In Vitro Diagnostics
